Shenouda Maged 4
4 · RELMADA THERAPEUTICS, INC. · Filed Dec 20, 2022
Insider Transaction Report
Form 4
Shenouda Maged
Chief Financial Officer
Transactions
- Award
Stock Option (right to buy)
2022-12-16+194,917→ 194,917 totalExercise: $3.37From: 2023-03-16Exp: 2032-12-16→ Common Stock (194,917 underlying)
Footnotes (1)
- [F1]62,560 of the shares are immediately vested; 132,357 shares vest in 16 equal quarterly installments commencing on March 16, 2023.